| Insideraktier | 152.417.701 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
UNIVERSAL BIOSENSORS INC insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i UBI / UNIVERSAL BIOSENSORS INC. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i UBI / UNIVERSAL BIOSENSORS INC. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-11 | 3 | Mullin Peter George | UBI | Common Stock | D | 444.424 | ||||||||
| 2025-02-11 | 3 | Mullin Peter George Mullin Family Superannuation Fund | UBI | Common Stock | I | 1.519.261 | ||||||||
| 2025-02-11 | 3 | Mullin Peter George Mullin Family Trust | UBI | Common Stock | I | 577.000 | ||||||||
| 2024-05-28 | 2024-05-27 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1100 | 275.000 | 30 | 1.561.217 | ||||
| 2024-05-28 | 2024-05-27 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1100 | 275.000 | 30 | 1.080.116 | ||||
| 2024-05-28 | 2024-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1100 | 1.421.293 | 156 | 87.509.318 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,1500 | 217.182 | 33 | 970.802 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1500 | 29.289.424 | 4.393 | 86.088.025 | ||||
| 2024-05-03 | 2024-05-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,1500 | 180.116 | 27 | 805.116 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By superannuation fund | UBI | Common Stock | I | 0,1500 | 30.000 | 4 | 394.666 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,1500 | 23.055 | 3 | 103.055 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 0,1500 | 10.000 | 2 | 1.286.217 | ||||
| 2024-05-03 | 2024-05-01 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,1500 | 99.077 | 15 | 442.873 | ||||
| 2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | -1.000.000 | 80.000 | ||||||
| 2024-05-03 | 2024-03-25 | 4 | Sharman John Stewart By wife | UBI | Common Stock | I | 1.000.000 | 1.276.217 | ||||||
| 2024-03-26 | 2024-03-25 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1.000.000 | 200 | 56.798.601 | ||||
| 2024-03-25 | 2024-03-25 | 4 | Sharman John Stewart | UBI | Common Stock | D | 0,2000 | 1.364.666 | 273 | 1.444.666 | ||||
| 2023-12-11 | 2023-12-11 | 4 | McLean Graham A Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust | UBI | Common Stock | I | 0,1987 | 75.000 | 15 | 625.000 | ||||
| 2023-09-13 | 2023-09-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2200 | 100.000 | 22 | 753.620 | ||||
| 2023-08-21 | 2023-06-30 | 4 | Hoey David L | UBI | Common Stock | D | 0,1679 | 95.983 | 16 | 662.397 | ||||
| 2023-03-15 | 2023-03-14 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2500 | 150.000 | 38 | 550.000 | ||||
| 2023-01-03 | 2023-01-01 | 4 | Balak Salesh | UBI | Common Stock | D | 50.000 | 388.558 | ||||||
| 2023-01-03 | 2023-01-01 | 4 | Sharman John Stewart | UBI | Common Stock | D | 50.000 | 80.000 | ||||||
| 2022-12-13 | 2022-12-12 | 4 | McLean Graham A | UBI | Common Stock | I | 0,2300 | 200.000 | 46 | 400.000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 17.848 | 4 | 653.620 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2400 | 82.152 | 20 | 635.772 | ||||
| 2022-11-16 | 2022-11-11 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2500 | 50.000 | 12 | 553.620 | ||||
| 2022-08-18 | 2022-08-17 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,2800 | 200.000 | 56 | 503.620 | ||||
| 2022-06-21 | 2022-05-27 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,7700 | 43.796 | 34 | 343.796 | ||||
| 2022-06-15 | 2022-06-09 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,3800 | 25.000 | 10 | 303.620 | ||||
| 2022-06-01 | 2022-06-01 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 96.613 | 44 | 200.000 | ||||
| 2022-06-01 | 2022-05-31 | 4 | McLean Graham A | UBI | Common Stock | I | 0,4600 | 3.387 | 2 | 103.387 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $1.00) | I | 1.920.000 | 1.920.000 | ||||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.92) | I | 1.920.000 | 1.920.000 | ||||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Stock Option (Right to Buy - Exercise Price $0.20) | I | 0,5700 | 1.000.000 | 570 | 1.000.000 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,4350 | 1.280.000 | 557 | 55.798.601 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7700 | 25.893.617 | 19.938 | 54.518.601 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,7700 | 10.000 | 8 | 278.620 | ||||
| 2022-05-31 | 2022-05-24 | 4 | Coleman Craig E. By the Coleman Super Fund | UBI | Common Stock | I | 0,4800 | 48.620 | 23 | 268.620 | ||||
| 2022-05-31 | 2022-05-27 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 0,5700 | -1.000.000 | -570 | 0 | |||
| 2022-05-27 | 2022-05-27 | 4 | Balak Salesh | UBI | Common Stock | D | 0,7700 | 2.000 | 2 | 338.558 | ||||
| 2022-05-13 | 2022-05-12 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 64.962 | 32 | 100.000 | ||||
| 2022-05-13 | 2022-05-11 | 4 | McLean Graham A Stock acquired by Graham McLean Family Trust of which Graham McLean is a member | UBI | Common Stock | I | 0,5000 | 35.038 | 18 | 35.038 | ||||
| 2022-02-28 | 2022-02-24 | 4 | Balak Salesh | UBI | Common Stock | D | 30.000 | 336.558 | ||||||
| 2022-02-28 | 2022-02-24 | 4 | Sharman John Stewart | UBI | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-11-05 | 2021-11-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 329.613 | 247 | 28.624.984 | ||||
| 2021-11-05 | 2021-11-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7490 | 152.638 | 114 | 28.295.371 | ||||
| 2021-11-05 | 2021-11-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,7300 | 896.506 | 654 | 28.142.733 | ||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 250.000 | 250.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Performance Rights | D | 500.000 | 500.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Balak Salesh | UBI | Common Stock | D | 40.000 | 306.558 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 1.250.000 | 1.250.000 | ||||||
| 2021-09-14 | 2021-08-19 | 4 | Sharman John Stewart | UBI | Performance Rights | D | 2.500.000 | 2.500.000 | ||||||
| 2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart By wife | UBI | Stock Option (Right to Buy) | I | 0,20 | 1.000.000 | 1.000.000 | |||||
| 2021-09-14 | 2020-03-24 | 4 | Sharman John Stewart | UBI | Stock Option (Right to Buy) | D | 0,20 | -1.000.000 | 1.364.666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | -12.559.109 | 27.246.227 | ||||||
| 2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2020-12-23 | 2020-12-11 | 4 | Balak Salesh | UBI | Common Stock | D | 40.000 | 266.558 | ||||||
| 2020-11-03 | 2020-11-02 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3100 | 200.000 | 62 | 300.000 | ||||
| 2020-09-15 | 2020-09-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 784.687 | 267 | 39.805.336 | ||||
| 2020-09-15 | 2020-09-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3300 | 80.178 | 26 | 39.020.649 | ||||
| 2020-09-15 | 2020-09-10 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 135.135 | 44 | 38.940.471 | ||||
| 2020-09-09 | 2020-09-01 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,30 | 500.000 | 500.000 | |||||
| 2020-09-08 | 2020-09-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3250 | 322.315 | 105 | 38.805.336 | ||||
| 2020-09-08 | 2020-09-04 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3040 | 284.962 | 87 | 38.483.021 | ||||
| 2020-09-08 | 2020-09-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3210 | 100.000 | 32 | 38.198.059 | ||||
| 2020-07-30 | 2020-07-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2500 | 730.999 | 183 | 12.559.109 | ||||
| 2020-07-30 | 2020-07-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2500 | 1.461.998 | 365 | 38.098.059 | ||||
| 2020-07-09 | 2020-07-07 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2200 | -23.820.765 | -5.241 | 0 | ||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2020-06-08 | 3 | Sharman John Stewart By wife | UBI | Common Stock | I | 552.434 | ||||||||
| 2019-12-02 | 2019-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 119.519 | 24 | 36.636.061 | ||||
| 2019-12-02 | 2019-11-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2000 | 1.885.217 | 377 | 36.516.542 | ||||
| 2019-12-02 | 2019-11-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1910 | 214.783 | 41 | 34.631.325 | ||||
| 2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-11-25 | 2019-11-12 | 4 | Balak Salesh | UBI | Common Stock | D | 25.000 | 226.558 | ||||||
| 2019-11-18 | 2019-11-15 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 36.500 | 7 | 34.416.542 | ||||
| 2019-11-18 | 2019-11-13 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1860 | 669.597 | 125 | 34.380.042 | ||||
| 2019-11-18 | 2019-11-01 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1800 | -3.439.866 | -619 | 18.442.469 | ||||
| 2019-09-12 | 2019-09-12 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 80.000 | 15 | 21.882.335 | ||||
| 2019-09-12 | 2019-09-11 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,1900 | 1.710.683 | 325 | 21.802.335 | ||||
| 2019-09-12 | 2019-09-12 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 80.000 | 15 | 33.710.445 | ||||
| 2019-09-12 | 2019-09-11 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,1900 | 1.710.683 | 325 | 33.630.445 | ||||
| 2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -73.334 | 0 | |||||
| 2019-07-09 | 2019-05-29 | 4 | Balak Salesh | UBI | Common Stock | D | 73.334 | 201.558 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -105.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -40.000 | 0 | |||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40.000 | 291.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 40.000 | 291.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 25.000 | 211.837 | ||||||
| 2019-03-06 | 2019-02-28 | 4 | Oates Adrian | UBI | Common Stock | D | 105.000 | 186.837 | ||||||
| 2019-03-06 | 2019-03-05 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 176.151 | 37 | 23.820.765 | ||||
| 2019-03-05 | 2019-03-01 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 100.000 | 21 | 23.644.614 | ||||
| 2019-01-14 | 2018-12-14 | 4 | Balak Salesh | UBI | Common Stock | D | 4.166 | 128.224 | ||||||
| 2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-01-14 | 2018-11-16 | 4 | Balak Salesh | UBI | Common Stock | D | 25.000 | 124.058 | ||||||
| 2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2019-01-14 | 2018-11-16 | 4 | Oates Adrian | UBI | Common Stock | D | 25.000 | 81.837 | ||||||
| 2019-01-14 | 2018-12-14 | 4 | Legleiter Rick L | UBI | Common Stock | D | 4.166 | 162.853 | ||||||
| 2018-12-06 | 2018-12-04 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2100 | 1.500.000 | 315 | 23.544.614 | ||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 3 | CVC Ltd | UBI | Common Stock | D | 43.889.228 | ||||||||
| 2018-11-05 | 2018-10-11 | 4 | CVC Ltd | UBI | Common Stock | D | 0,2300 | 100.000 | 23 | 22.044.614 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2400 | 66.584 | 16 | 31.915.182 | ||||
| 2018-05-11 | 2018-05-09 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2400 | 66.584 | 16 | 11.823.530 | ||||
| 2018-05-08 | 2018-05-04 | 4 | Legleiter Rick L | UBI | Common Stock | D | 0,2585 | 158.687 | 41 | 158.687 | ||||
| 2018-05-07 | 2018-05-07 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2320 | 198.640 | 46 | 31.848.598 | ||||
| 2018-05-07 | 2018-05-03 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2280 | 124.305 | 28 | 31.649.958 | ||||
| 2018-05-07 | 2018-05-07 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2320 | 198.640 | 46 | 11.756.946 | ||||
| 2018-05-07 | 2018-05-03 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2280 | 124.305 | 28 | 11.558.306 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Hoey David L | UBI | Common Stock | D | 0,2051 | 100.000 | 21 | 566.414 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Hoey David L | UBI | Common Stock | D | 0,2300 | 116.414 | 27 | 466.414 | ||||
| 2017-12-29 | 2017-12-29 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3000 | 750.318 | 225 | 11.434.001 | ||||
| 2017-12-29 | 2017-12-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2940 | 50.374 | 15 | 10.683.683 | ||||
| 2017-12-29 | 2017-12-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2890 | 56.245 | 16 | 10.633.309 | ||||
| 2017-12-29 | 2017-12-22 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,2690 | 33.613 | 9 | 10.577.064 | ||||
| 2017-12-29 | 2017-12-29 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,3000 | 2.250.953 | 675 | 20.091.652 | ||||
| 2017-12-29 | 2017-12-28 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2940 | 151.124 | 44 | 17.840.699 | ||||
| 2017-12-29 | 2017-12-27 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2890 | 168.737 | 49 | 17.689.575 | ||||
| 2017-12-29 | 2017-12-22 | 4 | VF Strategic Equities Fund | UBI | Common Stock | D | 0,2690 | 100.838 | 27 | 17.520.838 | ||||
| 2017-12-29 | 2017-12-29 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3000 | 3.001.271 | 900 | 31.525.653 | ||||
| 2017-12-29 | 2017-12-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2940 | 201.498 | 59 | 28.524.382 | ||||
| 2017-12-29 | 2017-12-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2890 | 224.982 | 65 | 28.322.884 | ||||
| 2017-12-29 | 2017-12-22 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,2690 | 134.451 | 36 | 28.097.902 | ||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,80 | 3.300.000 | 3.300.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,60 | 2.700.000 | 2.700.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Legleiter Rick L | UBI | Stock Option (Right to Buy) | D | 0,50 | 1.600.000 | 1.600.000 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -16.667 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Balak Salesh | UBI | Common Stock | D | 16.667 | 99.058 | ||||||
| 2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy | D | 0,00 | -25.000 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Chambers Garry | UBI | Common Stock | D | 25.000 | 2.275.594 | ||||||
| 2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2017-10-26 | 2017-10-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 25.000 | 2.871.615 | ||||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -16.667 | 0 | |||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | -25.000 | 0 | |||||
| 2017-08-17 | 2017-08-16 | 4 | Oates Adrian | UBI | Common Stock | D | 41.667 | 56.837 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.846.615 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3.030 | 15.170 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.250.594 | ||||||
| 2017-03-27 | 2016-12-28 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3.030 | 82.391 | ||||||
| 2017-03-01 | 2017-03-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3800 | 32.988 | 13 | 10.543.451 | ||||
| 2017-03-01 | 2017-02-28 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3850 | 247.001 | 95 | 10.510.463 | ||||
| 2017-03-01 | 2017-02-27 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3820 | 402.924 | 154 | 10.263.462 | ||||
| 2017-03-01 | 2017-03-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3800 | 32.988 | 13 | 27.963.451 | ||||
| 2017-03-01 | 2017-02-28 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3850 | 247.001 | 95 | 27.930.463 | ||||
| 2017-03-01 | 2017-02-27 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3820 | 402.924 | 154 | 27.683.462 | ||||
| 2017-02-17 | 2017-02-17 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3650 | 65.000 | 24 | 100.000 | ||||
| 2017-02-17 | 2017-02-14 | 4 | Smith Judith Ann Stock acquired by trustee of a superannuation fund of which Judith Smith is a member and beneficiary | UBI | Common Stock | I | 0,3350 | 35.000 | 12 | 35.000 | ||||
| 2017-02-16 | 2017-02-14 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3400 | 7.782 | 3 | 9.860.538 | ||||
| 2017-02-16 | 2017-02-14 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3400 | 7.782 | 3 | 27.280.538 | ||||
| 2017-01-03 | 2016-12-29 | 4 | Hodges Alastair | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.846.615 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Balak Salesh | UBI | Restricted Shares of Common Stock | D | 3.030 | 82.391 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Chambers Garry | UBI | Restricted Shares of Common Stock | D | 3.030 | 2.250.594 | ||||||
| 2017-01-03 | 2016-12-29 | 4 | Oates Adrian | UBI | Restricted Shares of Common Stock | D | 3.030 | 15.170 | ||||||
| 2016-12-08 | 2016-12-06 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3347 | 16.078 | 5 | 27.272.756 | ||||
| 2016-12-08 | 2016-12-06 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3347 | 16.078 | 5 | 9.852.756 | ||||
| 2016-12-05 | 2016-12-05 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3282 | 112.009 | 37 | 27.256.678 | ||||
| 2016-12-05 | 2016-12-02 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3200 | 165.000 | 53 | 27.144.669 | ||||
| 2016-12-05 | 2016-12-01 | 4 | Coleman Craig E. By Partnership | UBI | Common Stock | I | 0,3196 | 1.807.004 | 578 | 26.979.669 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF Australian Equities Fund | UBI | Common Stock | D | 0,3200 | -154.736 | -50 | 0 | ||||
| 2016-12-05 | 2016-12-05 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3282 | 112.009 | 37 | 9.836.678 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 154.736 | 50 | 9.724.669 | ||||
| 2016-12-05 | 2016-12-02 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3200 | 165.000 | 53 | 9.569.933 | ||||
| 2016-12-05 | 2016-12-01 | 4 | VF High Conviction Fund | UBI | Common Stock | D | 0,3196 | 1.807.004 | 578 | 9.404.933 | ||||
| 2016-09-30 | 2016-09-28 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 150.000 | 44 | 350.000 | ||||
| 2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309.472 | ||||||||
| 2016-07-20 | 3 | VF Australian Equities Fund | UBI | Common Stock | D | 309.472 | ||||||||
| 2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15.195.858 | ||||||||
| 2016-07-20 | 3 | VF High Conviction Fund | UBI | Common Stock | D | 15.195.858 | ||||||||
| 2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34.840.000 | ||||||||
| 2016-07-20 | 3 | VF Strategic Equities Fund | UBI | Common Stock | D | 34.840.000 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25.612.665 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50.565.330 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By the Coleman Super Fund | UBI | Common stock, par value US$0.0001 | I | 25.612.665 | ||||||||
| 2016-07-11 | 3 | Coleman Craig E. By partnership | UBI | Common stock, par value US$0.0001 | I | 50.565.330 | ||||||||
| 2016-06-14 | 2016-06-10 | 4 | Hoey David L | UBI | Common Stock | D | 0,2900 | 200.000 | 58 | 200.000 | ||||
| 2016-02-26 | 2016-02-17 | 4 | Balak Salesh | UBI | Common Stock | D | 2.500 | 79.361 | ||||||
| 2016-02-26 | 2016-02-17 | 4 | Oates Adrian | UBI | Common Stock | D | 2.500 | 12.140 | ||||||
| 2016-02-25 | 2016-02-17 | 4 | Hodges Alastair | UBI | Common stock | D | 2.500 | 2.843.585 | ||||||
| 2016-02-19 | 2016-02-17 | 4 | Chambers Garry | UBI | Common stock | D | 2.500 | 2.247.564 | ||||||
| 2016-02-19 | 2015-12-16 | 4 | Chambers Garry | UBI | Common stock | D | 0,4500 | -100.000 | -45 | 2.245.064 | ||||
| 2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,26 | -36.248 | 0 | |||||
| 2016-01-14 | 2015-12-31 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2600 | 36.248 | 9 | 2.841.085 | ||||
| 2016-01-14 | 2015-12-18 | 4 | Hodges Alastair | UBI | Common stock | D | 0,4600 | -30.000 | -14 | 2.804.837 | ||||
| 2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60.000 | 60.000 | |||||
| 2015-07-13 | 2015-07-09 | 4 | Wright Paul | UBI | Common stock | D | 4.347 | 7.304 | ||||||
| 2015-03-02 | 2015-02-20 | 4/A | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101.819,8200 | 337.428 | 34.356.858 | 337.428 | ||||
| 2015-03-02 | 2015-02-26 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 99.812,5700 | 269.088 | 26.858.365 | 606.516 | ||||
| 2015-02-24 | 2015-02-20 | 4 | Wright Paul By Chatsworth Trust | UBI | Common stock | I | 101.819,8200 | 337.428 | 34.356.858 | 337.428 | ||||
| 2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Hodges Alastair | UBI | Common Stock | D | 4.347 | 2.834.837 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Chambers Garry | UBI | Common Stock | D | 4.347 | 2.345.064 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Oates Adrian | UBI | Common Stock | D | 4.347 | 9.640 | ||||||
| 2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2015-02-03 | 2015-01-30 | 4 | Balak Salesh | UBI | Common Stock | D | 4.347 | 76.861 | ||||||
| 2014-06-13 | 2014-06-12 | 4 | Wright Paul | UBI | Common stock | D | 2.040 | 2.957 | ||||||
| 2014-06-13 | 2013-12-12 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 60.000 | 60.000 | |||||
| 2014-05-16 | 2014-05-15 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 7.670,0000 | 50.000 | 383.500 | 2.886.340 | ||||
| 2014-05-16 | 2014-05-14 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 8.940,0000 | 50.000 | 447.000 | 2.836.340 | ||||
| 2014-05-14 | 2014-05-14 | 4 | Hanley Denis | UBI | Common Stock | D | 8.127,9000 | 50.000 | 406.395 | 1.918.002 | ||||
| 2014-05-13 | 2014-05-13 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Colin Denver | UBI | Common Stock | I | 11.500,0000 | 50.000 | 575.000 | 2.786.340 | ||||
| 2014-05-13 | 2014-05-12 | 4 | DENVER ANDREW By wife | UBI | Common Stock | I | 6.610,5000 | 30.000 | 198.315 | 90.797 | ||||
| 2014-05-08 | 2014-05-06 | 4 | Smith Christopher M | UBI | Common Stock | D | 11.249,9500 | 30.000 | 337.498 | 30.000 | ||||
| 2014-04-16 | 2014-04-14 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 56.567,0800 | 142.105 | 8.038.465 | 186.771 | ||||
| 2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-08 | 2013-12-12 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 2.040 | 2.957 | ||||||
| 2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | -384.224 | 0 | |||||
| 2014-01-06 | 2013-12-24 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,2200 | 384.224 | 85 | 2.830.490 | ||||
| 2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Hodges Alastair | UBI | Common Stock | D | 2.040 | 2.446.266 | ||||||
| 2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Balak Salesh | UBI | Common Stock | D | 2.040 | 72.514 | ||||||
| 2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | -288.168 | 0 | |||||
| 2014-01-06 | 2013-12-24 | 4 | Chambers Garry | UBI | Common Stock | D | 0,2200 | 288.168 | 63 | 2.340.717 | ||||
| 2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Chambers Garry | UBI | Common Stock | D | 2.040 | 2.052.549 | ||||||
| 2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 40.000 | 40.000 | |||||
| 2014-01-06 | 2013-12-12 | 4 | Oates Adrian | UBI | Common Stock | D | 2.040 | 5.293 | ||||||
| 2013-10-09 | 2013-09-26 | 4 | Heinberg Marshall | UBI | Common Stock | D | 20.000 | 20.000 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW By Andrew Denver & Linda Denver & Allison Denver | UBI | Common Stock | I | 200.000 | 2.736.340 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | DENVER ANDREW | UBI | Common Stock | D | 28.000 | 437.050 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis Hanley Superannuation Fund Pty Ltd | UBI | Common Stock | I | 200.000 | 954.105 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis Denis M Hanley Pty Ltd | UBI | Common Stock | I | 6.000 | 54.889 | ||||||
| 2013-10-04 | 2013-09-26 | 4 | Hanley Denis | UBI | Common Stock | D | 29.772 | 1.868.002 | ||||||
| 2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,22 | -384.224 | 384.224 | |||||
| 2013-06-11 | 2013-06-11 | 4 | Hodges Alastair | UBI | Common Stock | D | 84.529,2800 | 384.224 | 32.478.178 | 2.444.226 | ||||
| 2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,22 | -288.168 | 288.168 | |||||
| 2013-06-11 | 2013-06-11 | 4 | Chambers Garry | UBI | Common Stock | D | 63.396,9600 | 288.168 | 18.268.975 | 2.050.509 | ||||
| 2013-05-28 | 2013-05-27 | 4 | Wright Paul | UBI | Common Stock | D | 917 | 917 | ||||||
| 2013-05-28 | 2012-11-13 | 4 | Wright Paul | UBI | Stock Option (Right to Buy) | D | 0,00 | 37.500 | 37.500 | |||||
| 2013-02-20 | 2013-02-12 | 4 | Oates Adrian | UBI | Common Stock | D | 7.291,3800 | -8.333 | -60.759 | 3.253 | ||||
| 2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW | UBI | Common Stock | I | 378.645,6800 | 676.153 | 256.022.412 | 2.536.340 | ||||
| 2013-01-08 | 2012-05-16 | 4 | DENVER ANDREW By spouse | UBI | Common Stock | I | 378.645,6800 | -676.153 | -256.022.412 | 60.797 | ||||
| 2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | I | 379.890,0000 | 678.375 | 257.707.879 | 1.860.187 | ||||
| 2013-01-08 | 2012-05-15 | 4 | DENVER ANDREW | UBI | Common Stock | D | 379.890,0000 | -678.375 | -257.707.879 | 409.050 | ||||
| 2012-12-28 | 2012-12-18 | 4 | Wilson Elizabeth | UBI | Common Stock | I | 3.999,6000 | 4.444 | 17.774 | 2.035.944 | ||||
| 2012-12-28 | 2012-12-19 | 4 | Balak Salesh | UBI | Common Stock | D | 1.999,8000 | 2.222 | 4.444 | 70.474 | ||||
| 2012-12-28 | 2012-12-18 | 4 | Wright Paul By Macquarie Super Manager | UBI | Common Stock | I | 14.999,4000 | 16.666 | 249.980 | 44.666 | ||||
| 2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Hodges Alastair | UBI | Common Stock | D | 917 | 2.060.002 | ||||||
| 2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Oates Adrian | UBI | Common Stock | D | 917 | 11.586 | ||||||
| 2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-23 | 2012-11-13 | 4 | Davis Frederick Harry | UBI | Common Stock | D | 917 | 917 | ||||||
| 2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-21 | 2012-11-13 | 4 | Balak Salesh | UBI | Common Stock | D | 917 | 68.252 | ||||||
| 2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Stock Option (Right to Buy) | D | 0,00 | 25.000 | 25.000 | |||||
| 2012-11-21 | 2012-11-13 | 4 | Chambers Garry | UBI | Common Stock | D | 917 | 1.762.341 | ||||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -8.333 | 0 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -8.333 | 0 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Stock Option (Right to Buy) | D | 0,00 | -21.666 | 73.334 | |||||
| 2012-08-27 | 2012-08-27 | 4 | Balak Salesh | UBI | Common Stock | D | 38.332 | 67.335 | ||||||
| 2012-08-27 | 2012-08-23 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 23.376 | 16 | 28.747 | ||||
| 2012-08-27 | 2012-08-22 | 4 | Davis Frederick Harry By wife | UBI | Common Stock | I | 0,7000 | 5.371 | 4 | 5.371 | ||||
| 2012-03-06 | 2012-02-27 | 4 | Hodges Alastair | UBI | Common Stock | D | 0,7300 | -1.000.000 | -730 | 2.059.085 | ||||
| 2012-01-24 | 2011-03-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -25.000 | -36 | 17.431.617 | ||||
| 2012-01-24 | 2011-03-04 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -24.000 | -34 | 17.456.617 | ||||
| 2012-01-24 | 2011-03-03 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -10.000 | -14 | 17.480.617 | ||||
| 2012-01-24 | 2011-03-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -34 | -0 | 17.490.617 | ||||
| 2012-01-24 | 2011-02-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -1.083 | -2 | 17.490.651 | ||||
| 2012-01-24 | 2011-02-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -2.590 | -4 | 17.491.734 | ||||
| 2012-01-24 | 2011-02-23 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -37.279 | -57 | 17.494.324 | ||||
| 2012-01-24 | 2011-02-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.531.603 | ||||
| 2012-01-24 | 2011-02-17 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3500 | -5.000 | -7 | 17.536.603 | ||||
| 2012-01-24 | 2011-02-16 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.541.603 | ||||
| 2012-01-24 | 2011-02-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -5.000 | -7 | 17.546.603 | ||||
| 2012-01-24 | 2011-02-11 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -22.463 | -31 | 17.551.603 | ||||
| 2012-01-24 | 2011-02-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -22 | -0 | 17.574.066 | ||||
| 2012-01-24 | 2011-02-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3700 | -10.000 | -14 | 17.574.088 | ||||
| 2012-01-24 | 2011-02-07 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -50.000 | -69 | 17.584.088 | ||||
| 2012-01-24 | 2011-02-02 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | -50.000 | -76 | 17.589.088 | ||||
| 2012-01-24 | 2011-02-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.639.088 | ||||
| 2012-01-24 | 2011-01-31 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | -50.000 | -75 | 17.689.088 | ||||
| 2012-01-24 | 2011-01-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.739.088 | ||||
| 2012-01-24 | 2011-01-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -17.869 | -27 | 17.789.088 | ||||
| 2012-01-24 | 2011-01-25 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -73 | -0 | 17.806.957 | ||||
| 2012-01-24 | 2011-01-24 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.807.030 | ||||
| 2012-01-24 | 2011-01-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.857.030 | ||||
| 2012-01-24 | 2011-01-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 17.907.030 | ||||
| 2012-01-24 | 2011-01-19 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -50.000 | -76 | 17.957.030 | ||||
| 2012-01-24 | 2011-01-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -50.000 | -76 | 18.007.030 | ||||
| 2012-01-24 | 2011-01-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4800 | -50.000 | -74 | 18.057.030 | ||||
| 2012-01-24 | 2011-01-13 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5000 | -50.000 | -75 | 18.107.038 | ||||
| 2012-01-24 | 2011-01-12 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | -50.000 | -74 | 18.157.030 | ||||
| 2012-01-24 | 2011-09-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 0,9600 | -1.500.000 | -1.440 | 15.749.937 | ||||
| 2012-01-24 | 2011-08-01 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,1900 | -752 | -1 | 17.249.937 | ||||
| 2012-01-24 | 2011-07-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3000 | -341 | -0 | 17.250.689 | ||||
| 2012-01-24 | 2011-04-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5300 | -10.000 | -15 | 17.251.030 | ||||
| 2012-01-24 | 2011-04-28 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5200 | -10.000 | -15 | 17.261.030 | ||||
| 2012-01-24 | 2011-04-27 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,5100 | -10.000 | -15 | 17.271.030 | ||||
| 2012-01-24 | 2011-04-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4900 | -35.000 | -52 | 17.281.030 | ||||
| 2012-01-24 | 2011-04-20 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4400 | -10.000 | -14 | 17.316.030 | ||||
| 2012-01-24 | 2011-04-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -8.000 | -11 | 17.326.030 | ||||
| 2012-01-24 | 2011-04-15 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -7.500 | -11 | 17.334.030 | ||||
| 2012-01-24 | 2011-04-14 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | -10.000 | -14 | 17.341.530 | ||||
| 2012-01-24 | 2011-03-30 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3900 | -155 | -0 | 17.351.530 | ||||
| 2012-01-24 | 2011-03-29 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3800 | -32 | -0 | 17.351.685 | ||||
| 2012-01-24 | 2011-03-21 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,3600 | -4.900 | -7 | 17.351.717 | ||||
| 2012-01-24 | 2011-03-10 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4000 | -25.000 | -35 | 17.356.617 | ||||
| 2012-01-24 | 2011-03-09 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4200 | -25.000 | -36 | 17.381.617 | ||||
| 2012-01-24 | 2011-03-08 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Development Corporation | UBI | Common Stock | I | 1,4100 | -25.000 | -35 | 17.406.617 |
